Abbott Laboratories' Q3 Earnings: Revenue And EPS Beat, Company Says Well-Positioned To Achieve Upper End Of Annual Forecast
Abbott Laboratories · PHARMACEUTICAL PREPARATIONS · Now $87.78
-3.6% in 7d after detection
Post-detection moves
1h
—
1d
-0.5%
3d
-1.6%
7d
-3.6%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS